Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AfriCann is a medical cannabis company focused on the cultivation, processing, and distribution of pharmaceutical-grade cannabis products across the African continent and international markets. The company operates large-scale cultivation facilities in regions such as Lesotho and South Africa, leveraging favorable climates and regulatory environments to produce high-quality cannabinoids. AfriCann's business model encompasses the entire value chain, from genetic research and cultivation to the manufacturing of standardized oils and isolates. By adhering to Good Agricultural and Collection Practices (GACP) and Good Manufacturing Practices (GMP), the company aims to provide safe and effective cannabinoid-based therapies for patients suffering from chronic pain, neurological disorders, and inflammatory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Africann.